Covid-19 antibody seroprevalence down at 25% in Delhi: Survey report in HC

Seroprevalence of antibodies to Covid-19 reduced to 25 per cent in September from nearly 29 per cent last month among people in the national capital, the Delhi High Court was informed

Coronavirus
A health worker collects a nasal sample from a man at a Mohalla Clinic to conduct tests for the coronavirus disease (COVID-19), amid the spread of the disease, at Greater Kailash in New Delhi on Wednesday
Press Trust of India New Delhi
2 min read Last Updated : Sep 30 2020 | 5:52 PM IST

Seroprevalence of antibodies to COVID-19 reduced to 25 per cent in September from nearly 29 per cent last month among people in the national capital, the Delhi High Court was informed on Wednesday.

These are the findings of the third round of sero surveillance carried out by the AAP government in the national capital between September 1 to September 7.

The report was placed before a bench of Justices Hima Kohli and Subramonium Prasad during the hearing on a PIL seeking increase in the COVID-19 testing numbers in the national capital and getting speedy results.

The report, filed through Delhi government additional standing counsel Satyakam, indicated that there was a reduction in the "antibody seroprevalence" from 28.7 per cent in August to 25.1 per cent in September.

It also showed that there was a significant decrease in seroprevalence in north east, north and central districts of Delhi, while there was a slight increase in south, east, west and north west districts.

The seroprevalence was more in females during all the rounds of the survey and it was the least in the 18-49 years age group, as compared to age groups of less than 18 years and more than 50 years, it said.

"Seroprevalence was increased in participants belonging to the low socio-economic status and those living in unplanned colonies," the report said and added that this was probably due to difficulties in maintaining social distancing and hygiene measures amongst people of these categories.

The Delhi government surveyed 17,409 people across the national capital.

The report stated that asymptomatic infections were manifested in most cases during all the sero survey rounds and diabetes mellitus was observed to be a risk factor for subclinical infection.

The sero survey also found that nearly one-third of the participants with a past history of COVID-19 infection, "did not have detectable IgG antibodies".

"However, there is evidence that antibodies to COVID-19 may deplete over time," it added.

The surveyors have recommended that there is a need to space the sero survey rounds and future surveillance should focus more on "ensuring representativeness of the sample in terms of settlement type and socio-economic status".

The Delhi government told the bench that it will inform the court on the next date of hearing on October 7 as to when it will conduct the next round of sero survey.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelhiDelhi High Court

First Published: Sep 30 2020 | 5:50 PM IST

Next Story